Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts

Journal of Virological Methods

Volumn 154, Issue 1-2, 2008, Pages 182-193

  Oliver, Stefan L ^a   Zerboni, Leigh ^a   Sommer, Marvin ^a   Rajamani, Jaya ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycoprotein; Herpesvirus; Immediate early protein; SCIDhu; Valacyclovir; Varicella zoster virus

Indexed keywords

GLYCOPROTEIN E; HYBRID PROTEIN; IMMEDIATE EARLY PROTEIN; LUCIFERASE; PROTEIN ORF63; PROTEIN ORF70; UNCLASSIFIED DRUG; VALACICLOVIR; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DORSAL ROOT; DRUG EFFECT; GANGLION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; VARICELLA ZOSTER VIRUS; VIRUS EXPRESSION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION; XENOGRAFT;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; GANGLIA, SPINAL; GENES, REPORTER; HERPESVIRUS 3, HUMAN; HUMANS; LUCIFERASES; LUMINESCENCE; MICE; MICE, SCID; RECOMBINANT FUSION PROTEINS; SKIN; STAINING AND LABELING; TRANSPLANTATION, HETEROLOGOUS; VALINE; VIRAL PROTEINS; WHOLE BODY IMAGING;

ANIMALIA; HERPESVIRIDAE; HUMAN HERPESVIRUS 3; MUS;

EID: 56249118322     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.07.033     Document Type: Article

References (45)

1. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image processing with ImageJ. Biophoton. Int. 11 (2004) 36-42
2. Baiker A., Bagowski C., Ito H., Sommer M., Zerboni L., Fabel K., Hay J., Ruyechan W., and Arvin A.M. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J. Virol. 78 (2004) 1181-1194
3. Berarducci B., Ikoma M., Stamatis S., Sommer M., Grose C., and Arvin A.M. Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. J. Virol. 80 (2006) 9481-9496
4. Besser J., Sommer M.H., Zerboni L., Bagowski C.P., Ito H., Moffat J., Ku C.C., and Arvin A.M. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J. Virol. 77 (2003) 5964-5974
5. Boeckh M., Kim H.W., Flowers M.E., Meyers J.D., and Bowden R.A. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation-a randomized double-blind placebo-controlled study. Blood 107 (2006) 1800-1805
6. Burgos J.S., Guzman-Sanchez F., Sastre I., Fillat C., and Valdivieso F. Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infection. Microb. Infect. 8 (2006) 1330-1338
7. Che X., Zerboni L., Sommer M.H., and Arvin A.M. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. J. Virol. 80 (2006) 3238-3248
8. Cohen J.I., Cox E., Pesnicak L., Srinivas S., and Krogmann T. The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J. Virol. 78 (2004) 11833-11840
9. Cohen J.I., Straus S.E., and Arvin A. Varicella-zoster virus replication, pathogenesis and management. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields' Virology (2007), Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia pp. 2 v (xix, 3091, 86 pp.)
10. Davison A.J., and McGeoch D.J. Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. J. Gen. Virol. 67 Pt 4 (1986) 597-611
11. Davison A.J., and Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67 Pt 9 (1986) 1759-1816
12. Debrus S., Sadzot-Delvaux C., Nikkels A.F., Piette J., and Rentier B. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol. 69 (1995) 3240-3245
13. Di Valentin E., Bontems S., Habran L., Jolois O., Markine-Goriaynoff N., Vanderplasschen A., Sadzot-Delvaux C., and Piette J. Varicella-zoster virus IE63 protein represses the basal transcription machinery by disorganizing the pre-initiation complex. Biol. Chem. 386 (2005) 255-267
14. Fiddian P., Sabin C.A., and Griffiths P.D. Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J. Infect. Dis. 186 Suppl. 1 (2002) S110-S115
15. Grose C. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu. Rev. Microbiol. 44 (1990) 59-80
16. Habran L., El Mjiyad N., Di Valentin E., Sadzot-Delvaux C., Bontems S., and Piette J. The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner. BMC Mol. Biol. 8 (2007) 99
17. Huynh T.H., Johnson M.W., Comer G.M., and Fish D.N. Vitreous penetration of orally administered valacyclovir. Am. J. Ophthalmol. 145 4 (2008) 682-686
18. Jones J.O., Sommer M., Stamatis S., and Arvin A.M. Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region. J. Virol. 80 (2006) 3116-3121
19. Kinchington P.R., Reinhold W.C., Casey T.A., Straus S.E., Hay J., and Ruyechan W.T. Inversion and circularization of the varicella-zoster virus genome. J. Virol. 56 (1985) 194-200
20. Luker G.D., Bardill J.P., Prior J.L., Pica C.M., Piwnica-Worms D., and Leib D.A. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J. Virol. 76 (2002) 12149-12161
21. Luker G.D., and Leib D.A. Luciferase real-time bioluminescence imaging for the study of viral pathogenesis. Methods Mol. Biol. 292 (2005) 285-296
22. Luker G.D., Prior J.L., Song J., Pica C.M., and Leib D.A. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J. Virol. 77 (2003) 11082-11093
23. Lycke J., Malmestrom C., and Stahle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob. Agents Chemother. 47 (2003) 2438-2441
24. Lynch J.M., Kenyon T.K., Grose C., Hay J., and Ruyechan W.T. Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins. Virology 302 (2002) 71-82
25. Mallory S., Sommer M., and Arvin A.M. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J. Virol. 71 (1997) 8279-8288
26. Manuel O., Kumar D., Singer L.G., Cobos I., and Humar A. Incidence and clinical characteristics of herpes zoster after lung transplantation. J. Heart Lung Transplant 27 (2008) 11-16
27. Mo C., Lee J., Sommer M., Grose C., and Arvin A.M. The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology 304 (2002) 176-186
28. Moffat J., Mo C., Cheng J.J., Sommer M., Zerboni L., Stamatis S., and Arvin A.M. Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. J. Virol. 78 (2004) 12406-12415
29. Moffat J.F., Stein M.D., Kaneshima H., and Arvin A.M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69 (1995) 5236-5242
30. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., and Arvin A.M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72 (1998) 965-974
31. Myers M.G., and Connelly B.L. Animal models of varicella. J. Infect. Dis. 1 166 Suppl. (1992) S48-50
32. O'Brien J.J., and Campoli-Richards D.M. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37 (1989) 233-309
33. Olson J.K., and Grose C. Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J. Virol. 71 (1997) 4042-4054
34. Sato B., Ito H., Hinchliffe S., Sommer M.H., Zerboni L., and Arvin A.M. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J. Virol. 77 (2003) 5607-5620
35. Sato B., Sommer M., Ito H., and Arvin A.M. Requirement of varicella-zoster virus immediate-early 4 protein for viral replication. J. Virol. 77 (2003) 12369-12372
36. Snyder A., Wisner T.W., and Johnson D.C. Herpes simplex virus capsids are transported in neuronal axons without an envelope containing the viral glycoproteins. J. Virol. 80 (2006) 11165-11177
37. Sommer M.H., Zagha E., Serrano O.K., Ku C.C., Zerboni L., Baiker A., Santos R., Spengler M., Lynch J., Grose C., Ruyechan W., Hay J., and Arvin A.M. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J. Virol. 75 (2001) 8224-8239
38. Soul-Lawton J., Seaber E., On N., Wootton R., Rolan P., and Posner J. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob. Agents Chemother. 39 (1995) 2759-2764
39. Stevenson D., Xue M., Hay J., and Ruyechan W.T. Phosphorylation and nuclear localization of the varicella-zoster virus gene 63 protein. J. Virol. 70 (1996) 658-662
40. Straus S.E., Owens J., Ruyechan W.T., Takiff H.E., Casey T.A., Vande Woude G.F., and Hay J. Molecular cloning and physical mapping of varicella-zoster virus DNA. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 993-997
41. Umene K. Mechanism and application of genetic recombination in herpesviruses. Rev. Med. Virol. 9 (1999) 171-182
42. Zerboni L., Ku C.C., Jones C.D., Zehnder J.L., and Arvin A.M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 6490-6495
43. Zerboni L., Reichelt M., Jones C.D., Zehnder J.L., Ito H., and Arvin A.M. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14086-14091
44. Zhang Z., Rowe J., Wang W., Sommer M., Arvin A., Moffat J., and Zhu H. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J. Virol. 81 (2007) 9024-9033
45. Zhao H., Doyle T.C., Coquoz O., Kalish F., Rice B.W., and Contag C.H. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J. Biomed. Opt. 10 (2005) 41210